Eli Lilly and Insilico Medicine have announced a drug discovery collaboration that uses Insilico’s AI engine to accelerate the discovery and development of novel therapeutics across...
Another key player in China’s biotech ecosystem has landed a pharma deal. On Sunday, Eli Lilly and Insilico Medicine announced a drug discovery collaboration, with the...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Insilico Medicine signed a large...
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning and happy Monday. I hope you...
Eli Lilly and Insilico Medicine are expanding a three-year partnership with a discovery and development collaboration that could generate more than $2.75 billion for the AI-based drug developer, Insilico said Sunday. Lilly has agreed...
Sanofi on Saturday shared more mixed efficacy results from a Phase 3 atopic dermatitis program for its anti-OX40 ligand monoclonal antibody, further eroding Wall Street’s already...
In mammalian hosts, the African trypanosome parasite replicates freely in the bloodstream, despite being fully exposed to the immune system. To do this, the pathogen relies...
AI can accelerate clinical work and preserve traceability, but only if users can trust it. Read More
6 FDA Decisions To Watch in Q2 2026
Common Pitfalls That Delay Regulatory Submissions, and How to Prevent Them
Scan to Read